Lipoteichoic acid (LTA), a key cell wall component of Gram-positive bacteria seems to function as an immune activator with characteristics very similar to lipopolysaccharide from Gram-negative bacteria. It has been shown that LTA binds CD14, and triggers activation via TLR2, but whether the activation occurs at the cell surface or whether internalisation is required in order to trigger signalling has yet to be demonstrated. In this study we have investigated LTA-binding and internalisation and found that LTA and its receptor molecules accumulate in lipid rafts and are subsequently rapidly targeted to the Golgi apparatus. This internalisation seems to be lipid raft dependent since raft-disrupting drugs inhibited LTA/TLR2 co-localisation in the Golgi. Similarly to LPS, LTA activation occurs at the cell surface and the observed trafficking is independent of signalling.
Introduction

Sepsis is an inflammatory response to infection either by Gram-negative or
Gram-positive bacteria that can lead to multi-organ failures and death (1) . This inflammatory response seems to be triggered by bacterial products, such as lipopolysaccharide (LPS) from Gram-negative bacteria, and lipoteichoic acid (LTA) from Gram-positive (2;3). It is now well established that the triggering of the host response occurs at the level of innate defence, without the need for antigen presentation or the clonal expansion of cells in order to fight the invading pathogens.
The recognition of these pathogen-associated molecular patterns (PAMPs) is mediated through germline-encoded receptors, called pattern recognition receptors.
At first glance it seems that both LPS and LTA activate the innate immune system via similar mechanisms of action. Both LPS and LTA bind CD14 (4-6), they activate signalling via Toll-like receptors (TLRs) (7) (8) (9) , they activate various tyrosine kinases (10) , and they both trigger NF-κB translocation (11) . On second glance though it seems that there are differences in host responses that follow cell activation. 4 The MyD88-independent pathway seems to involve the TIR domain-containing adaptor protein (TIRAP) (22) as well as TRIF (23) , and leads to the activation of NF-κB as well as IRF3 (24) . The existence of individual signalling pathways for each TLR may explain the distinct biological responses elicited by the different ligands.
It is now clear that the mechanism of LPS activation seems to require the formation of a receptor cluster that comprises of at least CD14, TLR4 and MD-2 (25) .
The possibility of the formation of even larger activation clusters has also been suggested (6;26) . Furthermore it has been recently shown that this activation is triggered at the cell surface in myeloid cells, and LPS is subsequently dragged to the Golgi apparatus along with CD14 and TLR4 (27) . In intestinal epithelial cells, LPS seems to trigger TLR4-activation intracellularly within the Golgi apparatus (28) . In the case of LTA the mechanism is not as well understood. It has been shown that LTA binds CD14 (29) , and triggers activation via TLR2 (7;30) , but whether the activation occurs at the cell surface or whether internalisation is required in order to trigger
signalling has yet to be demonstrated.
In this study we have chosen to investigate the cell surface interactions as well as the intracellular trafficking of bacterial LTA. Using green fluorescent protein (GFP)-TLR2 we investigated the localisation of TLR2 and LTA at the cell surface, defined the subcellular localisation and trafficking of LTA by employing fluorescent imaging methods. Here we show that LTA associates with TLR2 at the cell surface within lipid rafts. LTA is subsequently internalised and rapidly reaches the Golgi apparatus independently of the clathrin interacting endocytic machinery. This transport pathway appears to be raft specific and receptors involved in LTA recognition, CD14 and TLR2, seem to follow it. 5 Overall our data suggest that TLR2 and LTA follow the considerable fluidity of lipid rafts between the plasma membrane and the Golgi complex in order to gain access to the cell. Our findings are in agreement with Latz et al. (27) and Nichols et. al (31) who have demonstrated a novel rapid recycling pathway from the plasma membrane to the Golgi that is followed by LPS and lipid raft markers. It seems that LTA binding induces the recruitment of TLR2 into membrane microdomains, and takes advantage of the internalisation of these domains in order to reach and accumulate in the Golgi apparatus. Similarly to LPS, LTA trafficking is independent of signalling. 7 plasmid containing huCD14 (pcDNA3-huCD14) was a kind gift from Dr D.T.
Golenbock (Univ. of Mass., Worcester, USA).
Stable cell lines
Stable transfections of HEK293 cells with pcDNA3, GFP-TLR2 or CD14 were performed using Superfect Transfection Reagent (Quiagen) according to the manufacturer's recommendations. Positive selection by fluorescence-activated cell sorting was performed. Clonal cell lines were obtained by limiting dilution.
Stably transfected cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 0,5 units/ml penicillin, 0,5 µg/ml streptomycin, 400 µg/ml G418 for HEK/pcDNA3, HEK/GFP-TLR2, HEK/CD14, HEK/GFP-TLR2/CD14 and 400 µg/ml hygromycin for HEK/GFP-TLR2/CD14.
The CHO/CD14/huTLR2 (3E10TLR2) reporter cell line was constructed by stable cotransfection of 3E10 with the cDNA for human TLR2 and pcDNA3 (Invitrogen), as described (33) . CHO cell lines were grown in Ham's F12 medium containing 10 % FCS and 1% Penicillin/Streptomycin. Medium was supplemented with 400 µg/ml G418 and 400 µg/ml hygromycin (3E10TLR2).
Luciferase reporter assays for NF-kB activation
HEK293 cells transfected with CD14 and GFP-TLR2 were seeded into 96 well plates.
The following day, the cells were transiently transfected with a NF-kB luciferase reporter gene using lipofectamine 2000 (Invitrogen, UK) according to the manufacturer's instructions. The next day the cells were stimulated as indicated and after 6 h of stimulation, the cells were lysed in passive lysis buffer (Promega).
Luciferase activity was measured using a plate reader luminometer.
TNF-α ELISA
Stably transfected HEK/GFP-TLR2/CD14 cells were plated on 24 well dishes (Nunc, Germany) at a concentration of 1x10 6 /ml in 300 µl DMEM and 10% FCS. The next day cells were stimulated for the indicated time period. Supernatants were collected and analysed for TNF-α with a commercial ELISA (Research Diagnostics Inc, UK).
Cell labelling for FRET
Stably transfected HEK/GFP-TLR2/CD14 were seeded on microchamber culture slides (Lab-tek, Gibco) and labelled with 100 µl of a 1:1 mixture of donor-conjugated antibody (Cy3) and acceptor conjugated antibody (Cy5). For control experiments in order to determine whether FRET is dependent on donor and acceptor surface density, the donor:acceptor ratio was varied to 1:2 and 1:4. The cells were rinsed twice in PBS/0.02% BSA, prior to fixation with 4% formaldehyde for 15 min. The cells were fixed in order to prevent potential re-organisation of the proteins during the course of the experiment.
Fluorescent imaging
HEK/GFP-TLR2/CD14 cells were grown on microchamber culture slides Cells were stimulated with 1 and 10 µg/ml of LTA, after different times post stimulation they were exposed to fluorescent stains for organelles and subsequently fixed with 4% formaldehyde for 15 min. For LTA and receptor staining fluorescent probes were added and incubated for 60 min in PBS/0.02% BSA/ 0.02% Saponin.
Then washed three times with PBS. The slides were mounted on Prolong antifadant (Molecular probes).
When specific inhibitory drugs were used, the chemicals (nocodazole, chloropromazine, nystatin, filipin) were added to the cell culture medium prior to stimulation for 30 min and they were also present during the course of LTA stimulation.
Cells were imaged on a Carl Zeiss, Inc. LSM510 META confocal microscope (with an Axiovert 200 fluorescent microscope) using a 1.4 NA 63x Zeiss objective.
The images were analysed using LSM 2.5 image analysis software (Carl Zeiss, Inc.).
FITC and TRITC were detected using the appropriate filter sets. Using typical exposure times for image acquisition (less than 5 s), no fluorescence was observed from a Cy3-labelled specimen using the Cy5 filters, nor was Cy5 fluorescence detected using the Cy3 filter sets.
In addition, cells were imaged on a CCD (charged cooled device) camerabased microscope system, consisting of a Carl Zeiss, Inc 200-inverted microscope with an Orca ER CCD camera (Improvision, UK). Openlab software was used to control the camera, whereas image analysis was carried out using Volocity software.
FRET measurements
FRET is a non-invasive imaging technique used to determine molecular proximity. FRET can occur over 1-10 nm distances, and effectively increases the resolution of light microscopy to the molecular level. It involves non-radiative transfer of energy from the excited state of a donor molecule to an appropriate acceptor. The rate of energy transfer is inversely proportional to the sixth power of the distance, between donor and acceptor. The efficiency of energy transfer (E) is defined with respect to r and R 0 , the characteristic Forster distance by:
In the present study, FRET was measured using a method as previously described (34;35) .
FRAP measurements
FRAP measurements were performed as previously described (36;37) . Briefly, slides containing labelled cells were placed onto a temperature controlled microscope stage (Physitemp, Model TS-4) and allowed to equilibrate to the desired temperature for FRAP measurements. After equilibration, the beam of an argon ion laser (Innova 100-10) was focused onto the desired area on the cell. The laser beam was of Gaussian cross-sectional intensity distribution, with a half-width at 1/e 2 height of the laser beam at its point of focus equal to 1.24 µm spot radius. FRAP measurements were recorded and analysed as previously described (36) . For intracellular FRAP experiments, the laser beam was focused inside the cell rather than on the cell surface.
Results
GFP-TLR2 fusion proteins are able to respond to LTA
Human embryonic kidney (HEK) 293 cells are normally unresponsive to LPS or LTA since they lack CD14, TLR4 and TLR2 expression. In this study we transfected HEK293 cells with CD14 or CD14 and GFP-TLR2, in order to be able to define the subcellular localisation and trafficking of TLR2 before and after stimulation by bacterial LTA. HEK293 cells transfected with CD14 and GFp-TLR2 successfully expressed TLR2 on the cell surface ( Figure 1A ), similarly to human monocytes ( Figure 1B ).
In order to establish that transfection of HEK293 cells with CD14 and TLR2 rendered them able to respond to LTA, we measured TNF-α secretion in HEK293, HEK/CD14 and HEK/GFP-TLR2/CD14 cells following LTA stimulation.
HEK293, HEK/CD14 and HEK/GFP-TLR2/CD14 cells, as well as human monocytes were stimulated with 10 µg/ml of LTA. In parallel as a control HEK293, HEK/CD14, HEK/GFP-TLR2/CD14 and human monocytes were stimulated with 100 ng/ml of LPS. After stimulation supernatants were collected and analysed for TNF-α using a commercial ELISA.
As expected it was shown that HEK293 cells were incapable of responding to either LPS or LTA. Transfection with CD14 did not make them responsive to bacterial products, whereas transfection with CD14 and TLR2 rendered them responsive to LTA but not to LPS ( Figure 1C ). Human monocytes expressing CD14, TLR4 and TLR2 ( Figure 1C ), were able to respond to both LPS and LTA. From these data we conclude that transfection of HEK293 cells with both CD14 and TLR2 enables them to respond to LTA. In addition, the fluorescent tag fused on the Cterminus of TLR2 does not seem to affect TLR2 function and thus GFP-TLR2 is a functional signalling receptor for LTA.
Cell surface interactions of LTA: FRET imaging of lipid rafts
It has been previously shown that the innate recognition of LPS takes place within lipid rafts or microdomains (38) . Lipid rafts are believed to perform diverse functions by providing a specialised microenvironment in which the relevant molecules for the specific biological processes are partitioned from the rest of the plasma membrane and are concentrated into the raft (39) . In order to investigate whether LTA recognition also occurs within lipid rafts fluorescence resonance energy transfer (FRET) was utilised.
We measured FRET in terms of dequenching of donor fluorescence after complete photobleaching of the acceptor fluorophore. Increased donor fluorescence after complete destruction of the acceptor indicated that the donor fluorescence was quenched in the presence of the acceptor because of energy transfer. We tested the energy transfer efficiency in our system using as a positive control the energy transfer from mAbs Cy3-W6/32 and Cy5-MCA1115 to two different epitopes on MHC-class I molecules (Table 1) , which showed that the maximum energy transfer efficiency (E) was 34±2.5.
In order to visualise whether LTA was localised in lipid rafts we measured FRET on HEK/CD14/huTLR2 cells between LTA (using Cy3-LTA-specific mAb)
and GM1 ganglioside, a raft associated lipid (using Cy5-cholera toxin). Dequenching was observed once the Cy5 was photobleached (E=24 ±1.0%) suggesting that most (~62%) of the LTA concentrates in the lipid rafts of the plasma membrane ( Figure 2 ).
Control experiments were performed with the Cy5-cholera toxin using Cy3-LTAspecific mAb without the presence of LTA. The results showed that the energy transfer efficiency was 1.2 ±0.5%, thus verifying that there was no non-specific interaction. In addition, control experiments were performed using the parental HEK293 cell line. It was found that barely detectable levels of LTA bound in the absence of CD14 (data not shown).
We similarly examined whether CD14 and TLR2 receptor molecules localise in lipid rafts prior to LTA stimulation, by using Cy3-26ic Fab specific for CD14 and Cy3-TLR2 specific mAb respectively and Cy5-cholera toxin for the GM1 ganglioside. Our results showed that there was FRET observed between CD14 and GM1 ganglioside (26 ±1.5%), thus CD14 was present in lipid rafts prior to LTA stimulation (Table 1 ). In contrast, there was no energy transfer between TLR2 and GM-1 ganglioside prior to LTA stimulation (6 ±1%), suggesting that similarly to TLR4, TLR2 does not reside in lipid rafts prior to stimulation ( Figure 2B ). Upon stimulation, we observed large dequenching (28 ±2%) between TLR2 and GM-1 ganglioside, thus suggesting that TLR2 is recruited within lipid rafts following LTA stimulation ( Figure 2D ). As expected upon LTA stimulation, CD14 remained within the lipid raft, since large dequenching was observed after Cy5-cholera toxin photobleaching. Control experiments investigating the association of TLR2 with GM-1 ganglioside after LPS stimulation were also performed. It was shown that TLR2 was not recruited in lipid rafts following LPS stimulation, since the energy transfer observed between TLR2 and GM1 ganglioside after LPS stimulation was 3±0.5%.
Similar results were obtained when human monocytes were utilised (Table 2 ).
In order to rule out the possibility that the FRET observed was due to random distribution, we varied the ratio of donors and acceptors used to label the proteins of interest ( Figure 2E ). E was found to be independent on acceptor density, to be sensitive to donor:acceptor ratio, and not to go to zero at low surface density, thus suggesting that the FRET values observed were due to clustered molecules and not random associations.
Entry route
In order to investigate the entry route of LTA into cells, we used vital stains for known vesicular compartments in cells as well as fluorescent probes for LTA (using a Cy5-specific LTA mAb) and CD14 (Cy5-26ic Fab).
We determined whether LTA or its receptors CD14, TLR2 are internalised into lysosomes using a freely permeant probe with a high selectivity for acidic organelles, Lysotraker Red DND-99 (40) . HEK/GFP-TLR2/CD14 were incubated for different time periods (5min, 15min, 30min, 60min) with 1 and 10 µg/ml of LTA in the presence of Lysotraker Red DND-99. Triple labelling with Lysotraker Red DND-99, LTA specific probe, or CD14-specific probe and GFP-TLR2 was performed. Our results showed that LTA did not colocalise within lysosomes (data not shown). following stimulation showed colocalisation of the LTA and GFP-TLR2 with the Golgi after 30 min stimulation. (Figure 3 ).
Effects of clathrin route inhibitors on LTA entry
In order to determine whether LTA and TLR2 utilise clathrin-coated pits for internalisation we used different clathrin inhibitors prior to LTA stimulation. We utilised various chemicals that we had tested and were not cytotoxic to the cells, such as nocodazole (20µM) and chloropromazine (25µM), as well as an anti-clathrin mAb.
Nocodazole is known to block endosomal traffic between early and late endosomes (44) , whereas chloropromazine causes the disappearance of clathrin coated pits from the cell membrane (45) .
Using triple fluorescent labelling we investigated the concentration of LTA as well as TLR2 in the Golgi apparatus after treatment with either nocodazole or chloropromazine. We found that neither nocodazole nor chloropromazine prevented the localisation of LTA and TLR2 with the Golgi (Figure 4B ). Pre-treatment of cells with these chemicals did not affect TNF-α secretion. Similar results were obtained when using an antibody specific for clathrin, suggesting that LTA/TLR2 entry into cells is clathrin-independent.
Effects of raft-disrupting drugs on LTA entry
Since we had already found that LTA and its receptor molecules localise in lipid rafts in the initial binding steps we investigated whether lipid raft-disrupting drugs such as nystatin (46) or filipin (47) which had been tested and were not cytotoxic at the optimal concentrations of 25µM and 1 µg/ml respectively, could inhibit LTA/TLR2 targeting to the Golgi apparatus. Fluorescent labelling revealed that treatment with either filipin or nystatin prevented LTA and TLR2 colocalisation to the Golgi ( Figure 4C ), leading us to believe that LTA/TLR2 entry and targeting to the Golgi apparatus is dependent on lipid raft integrity. The cells viability was not affected either by nystatin or filipin treatment as the drug treated cells excluded trypan blue.
In order to investigate whether the entire microdomain along with all the raftassociated receptors was being "dragged" to the Golgi apparatus we examined the translocation of Cy5-cholera toxin. HEK/CD14/GFP-TLR2 cells were incubated with Cy5-labelled cholera toxin, which binds to GM-1 ganglioside (a lipid raft marker). It was shown that the cholera toxin was rapidly targeted from the cell surface to the Golgi apparatus indistinguishably of LTA, CD14 and TLR2 ( Figure 5 ).
TLR2 intracellular mobility
Since TLR2 was found to be rapidly targeted to the Golgi along with bacterial LTA, we employed FRAP in order to determine the intracellular TLR2 mobility before and after LTA uptake. FRAP would be able to provide us with a diffusion coefficient D, as well as the extent of fluorescent recovery (mobile fraction). Thus we will be able to determine whether TLR2 associates with immobile or slow diffusing molecules intracellularly, if we observe a lower D after LTA stimulation. In addition we will be able to determine the percentage of molecules that are free to diffuse to and from the plasma membrane.
The intracellular diffusion of GFP-TLR2 prior to LTA stimulation was found to be (3.96 ± 1.0) x 10 -8 cm 2 /s with a percentage recovery of 68 ± 10%, suggesting that similarly to TLR4, TLR2 is a highly mobile receptor that diffuses freely and rapidly through intracellular compartments. Upon LTA stimulation, the lateral diffusion of TLR2 was found to be (2.79 ± 1.0) x 10 -8 cm 2 /s with a percentage recovery of 52 ± 8%. Thus suggesting that upon LTA stimulation, TLR2 seems to be diffusing slightly slower possibly because of its association with other intracellular
proteins. In addition we observed a reduction in percentage recovery suggesting that a percentage of the TLR2 pool seems not be able to freely diffuse, possibly because a small percentage (~10%) is being retained within the Golgi (Table 3) .
LTA trafficking in the presence and absence of TLR2
In order to determine whether the trafficking and targeting of LTA and TLR2
to the Golgi apparatus was required for LTA signalling we proceeded to investigate the trafficking of LTA in the absence of TLR2.
In the absence of TLR2, in HEK-CD14 cells there was rapid LTA binding and internalisation. LTA was rapidly targeted to the Golgi apparatus in the absence of TLR2. Using triple labelling we were able to visualise co-localisation of CD14, LTA and Con A (Figure 6 ), thus suggesting that the intracellular targeting to the Golgi is not TLR2-dependent. In addition, CD14-mediated binding and uptake of LTA occurred in the absence of signalling, since stimulation of HEK-CD14 cells with LTA did not result in MyD88 translocation (data not shown) or TNF-α secretion ( Figure   1 ).
To further examine the significance of the LTA-Golgi-localisation we disrupted the Golgi of human monocytes by adding brefeldin A (48). In brefeldin Apre-treated cells, Golgi was disrupted and LTA disappeared from the perinuclear area ( Figure 7B ). However, despite its re-location NF-κB activation in brefeldin A-treated cells was not diminished ( Figure 7C ). Since LTA internalisation and trafficking occurred in the absence of TLR2, and disruption of the LTA-localisation in the Golgi did not affect NF-κB activation, it is apparent that internalisation and trafficking is neither sufficient nor necessary for LTA-induced activation.
LTA induces TLR2 clustering
In order to verify that signal transduction is initiated from the plasma membrane, we also investigated the cell surface TLR2 distribution in response to LTA. HEK/CD14/GFPTLR2 cells were stimulated with 10 µg of LTA and imaged by confocal microscopy. It has shown that upon LTA stimulation, cell surface TLR2 seemed to form large clusters (Figure 8 ). In order to investigate whether signalling was initiated via these clusters, we analysed the location of MyD88 before and after LTA stimulation. Prior to LTA stimulation, MyD88 was found to be expressed in cytoplasmic aggregates ( Figure 8A ). Upon LTA stimulation, it was found that MyD88
was recruited towards the cell surface and co-localised with the TLR2 clusters ( Figure   8B ), thus suggesting that signalling is initiated via clustering of receptor molecules on the cell surface.
Discussion
The increased prevalence of Gram-positive sepsis has sparked an interest in identifying the molecular mechanisms that are involved in the host response to components of these organisms. LTA, a key cell wall component of Gram-positive bacteria seems to function as an immune activator with characteristics very similar to LPS. Although these two bacterial components seem to induce the same end result (49) , there seem to be significant difference between sepsis caused by Gram positive and Gram negative bacteria, mainly in the host responses against them (50) . In this study we have chosen to investigate whether LTA-binding and internalisation is similar to that which has recently been reported for bacterial LPS (27) .
In order to perform this study we engineered fusion protein of green fluorescent protein with TLR2. We transfected HEK293 cells with CD14 and GFP-TLR2 and demonstrated that GFP-TLR2 is a fully functional receptor for bacterial LTA and triggers identical immune responses with cells that natively express TLR2.
Initially we looked at the distribution on the plasma membrane of LTA, CD14, as well as TLR2, in order to determine whether they reside in membrane microdomains or lipid rafts. Using FRET we found that LTA as well as both CD14
and TLR2 are concentrated within lipid rafts on the plasma membrane upon LTA stimulation. CD14, which is a GPI linked protein seems to be constitutively localised in lipid rafts (38;51), whereas TLR2 was found not to reside in lipid rafts prior to LTA stimulation, but to increasingly accumulate in the raft upon the presence of LTA.
Following LTA-binding we attempted to track the entry route of LTA and its receptors within the cell. In order to elucidate LTA entry, we utilised triple labelling fluorescent imaging to visualise LTA, TLR2 and markers for different intracellular compartments. We found that LTA and TLR2 did not co-localise with lysosomes, endosomes or ER over different time periods following LTA stimulation. In contrast it was found that both LTA and TLR2 were rapidly targeted to the Golgi apparatus and specifically to the cis-Golgi network 30 min following LTA stimulation. CD14
followed the same route. These data are in good agreement with previous studies performed with bacterial LPS (27;52).
In an attempt to verify whether the entry of LTA and its receptor molecules was dependent on clathrin-coated pits we utilised different clathrin inhibitors prior to stimulation with LTA. Anti-clathrin specific antibody as well as chemicals such as nocodazole and chloropromazine, which are known to block endosomal traffic between early and late endosomes (44) , and to cause the disappearance of clathrin coated pits from the cell membrane(45) respectively were utilised. Neither the chemicals nor the mAb could inhibit LTA/TLR2 internalisation. Furthermore using triple labelling we visualised LTA, TLR2 and Golgi markers. We found that preincubation with the clathrin-route inhibitors did not affect LTA/TLR2 targeting to the Golgi, thus suggesting that LTA along with TLR2 gain entrance and are targeted to the Golgi via a clathrin-independent route.
In addition, LTA internalisation seemed to be lipid raft dependent. In the presence of lipid raft disrupting drugs, such as nystatin or filipin, targeting of LTA and TLR2 to the Golgi network was inhibited upon disruption of the lipid raft integrity. Our studies suggest that lipid raft formation is crucial for LTA internalisation and trafficking. Previous observations have shown that the entire cholesterol, ganglioside-rich microdomain or "lipid raft", where we have shown that LTA, CD14 and TLR2 reside, is constantly shuttling back and forth from the cell surface to the Golgi (31;53;53). Our studies confirm this since when we incubated HEK/CD14/GFP-TLR2 cells with Cy5-labelled cholera toxin, which binds to GM-1 ganglioside (a lipid raft marker), the cholera toxin was rapidly targeted from the cell surface to the Golgi apparatus indistinguishably of LTA, CD14 and TLR2.
Our data suggests that LTA is dragged to the Golgi along with the lipid raft containing CD14 and TLR2 via a novel clathrin-independent endocytic route. There seems to be a plasma membrane-Golgi cycling pathway that is followed by sphingolipids which make up lipid rafts.
When we utilised FRAP in order to investigate TLR2 intracellular mobility before and after LTA stimulation, we found that prior to LTA stimulation TLR2 exhibited a very fast diffusion coefficient and a high percentage recovery indicative of a molecule that diffuses rapidly without any barriers throughout intracellular compartments. Upon LTA stimulation, TLR2 exhibited a slower diffusion coefficient and a lesser percentage recovery suggesting that upon stimulation by LTA, TLR2
seemed to associate with other intracellular proteins and/or to be retained in the Golgi (the compartment that it seems to be residing in).
The question that we had to answer was whether the internalisation and trafficking that we observed was crucial for LTA signalling. Over the years it had been suggested that this might be the case for LPS-induced signalling (28;52), although it has recently been shown that LPS-internalisation is independent of signal transduction (27) . In order to answer this question in the case of LTA, we performed confocal experiments with HEK-CD14 that were shown not to be able to respond to bacterial LTA. It was found that LTA was internalised and rapidly targeted to the Golgi in the absence of TLR2. Brefeldin A disruption of the Golgi, showed that TLR2/LTA localisation in the Golgi is not essential for signalling and cytokine secretion. On the contrary we found that similarly to LPS (27) , LTA must engage its receptors on the cell membrane where signalling is initiated. Thus our data are in agreement with Latz et al. (27) who have demonstrated that LPS-internalisation is independent of signal transduction, but are in contrast to a recent report by Blander
and Medzhitov who showed that the internalisation of E.Coli to the phagosome is dependent on TLR-signals (54) . The reason for these conflicting reports might be the fact that Blander and Medzhitov used whole bacteria and not bacterial products, such as LPS or LTA, in their study. It is possible that whole bacteria, due to the difference in particle size, are internalised by a different mechanism when compared to bacterial products.
Our study, which utilises bacterial products, suggests that TLR2 forms clusters in response to LTA, most likely within lipid rafts, that result in signalling. It is possible that within these clusters other molecules might associate with TLR2, since it has been previously shown that it can heterodimerize with either TLR1 or TLR6 in response to different pathogens (55) (56) (57) . Once TLR2 has been engaged by LTA, clustering occurs, which leads to signalling. Subsequently the entire microdomain, along with the receptors that have clustered there, is internalised and targeted to the Golgi. One possible explanation for this could be that following cellular activation, the plasma membrane is re-organised, TLR molecules are internalised in order to be re-cycled back to the surface, and LTA is targeted to the Golgi for clearance. Thus the process of internalisation and intracellular trafficking of LTA is completely independent of signalling and is consistent with the hypothesis that cellular activation in response to bacterial products occurs at the cell surface. 
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